| NCT04364763 |
A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) |
https://ClinicalTrials.gov/show/NCT04364763 |
Recruiting |
Renibus Therapeutics, Inc. |
2021-06-30 |
| NCT04288856 |
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT04288856 |
Enrolling by invitation |
Biogen |
2023-07-19 |
| NCT03312738 |
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor |
https://ClinicalTrials.gov/show/NCT03312738 |
Active, not recruiting |
Novartis |
2020-05-19 |
| NCT03205956 |
Measuring Parkinson’s Disease Progression |
https://ClinicalTrials.gov/show/NCT03205956 |
Completed |
Washington University School of Medicine |
2019-10-18 |
| NCT03202914 |
Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression |
https://ClinicalTrials.gov/show/NCT03202914 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
1993-05-31 |
| NCT03192579 |
Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial |
https://ClinicalTrials.gov/show/NCT03192579 |
Completed |
Kobe University |
2017-06-02 |
| NCT03174912 |
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? |
https://ClinicalTrials.gov/show/NCT03174912 |
Completed |
Ankara Training and Research Hospital |
2016-12-31 |
| NCT03154190 |
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT03154190 |
Recruiting |
Stanford University |
2020-11-30 |
| NCT03150602 |
A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy |
https://ClinicalTrials.gov/show/NCT03150602 |
Recruiting |
Taiwan Mundipharma Pharmaceuticals Ltd. |
2020-12-31 |
| NCT03086512 |
A Study Comparing Computerized Tomographic Progression of Bone Bridging After Subtalar Fusion Using Fully and Partially Threaded Screws |
https://ClinicalTrials.gov/show/NCT03086512 |
Recruiting |
St. Paul’s Hospital, Canada |
2022-04-30 |
| NCT03014869 |
High Flow Nasal Cannula vs NPPV in Moderate Chronic Obstructive Pulmonary Disease Exacerbation |
https://ClinicalTrials.gov/show/NCT03014869 |
Recruiting |
China-Japan Friendship Hospital |
2020-12-31 |
| NCT03003559 |
HFNC vs Nasal Cannula in Mild Chronic Obstructive Pulmonary Disease Exacerbation |
https://ClinicalTrials.gov/show/NCT03003559 |
Recruiting |
China-Japan Friendship Hospital |
2020-12-31 |
| NCT02959749 |
Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02959749 |
Completed |
Qingdao Central Hospital |
2017-10-31 |
| NCT02937597 |
E-learning Proficiency Based Progression Training Programme for Clinical Communication on ISBAR Performance (eISBAR) |
https://ClinicalTrials.gov/show/NCT02937597 |
Completed |
University College Cork |
2018-04-30 |
| NCT02886754 |
Proficiency-Based Progression Training for Clinical Communication |
https://ClinicalTrials.gov/show/NCT02886754 |
Completed |
University College Cork |
2016-09-16 |
| NCT02863718 |
Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression |
https://ClinicalTrials.gov/show/NCT02863718 |
Active, not recruiting |
German CLL Study Group |
2019-03-07 |
| NCT02816645 |
One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson’s Disease Progression? |
https://ClinicalTrials.gov/show/NCT02816645 |
Recruiting |
University Hospital, Clermont-Ferrand |
2020-06-30 |
| NCT02789020 |
Image Parkinson’s Disease Progression Study |
https://ClinicalTrials.gov/show/NCT02789020 |
Active, not recruiting |
University of Florida |
2020-12-31 |
| NCT02744976 |
Coronary Artery Disease Progression in Patients With Prediabetes |
https://ClinicalTrials.gov/show/NCT02744976 |
Recruiting |
Pauls Stradins Clinical University Hospital |
2018-12-31 |
| NCT02681809 |
A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR |
https://ClinicalTrials.gov/show/NCT02681809 |
Completed |
Oxurion |
2019-11-18 |
| NCT02661191 |
Vitamin D Deficiency and Asthma Exacerbation |
https://ClinicalTrials.gov/show/NCT02661191 |
Completed |
University of Turin, Italy |
2013-03-31 |
| NCT02643875 |
Investigation of the Effect of Short-term Orthokeratology With Increased Compression Factor on Ocular Parameters |
https://ClinicalTrials.gov/show/NCT02643875 |
Completed |
The Hong Kong Polytechnic University |
2016-11-18 |
| NCT02643342 |
A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye |
https://ClinicalTrials.gov/show/NCT02643342 |
Active, not recruiting |
The Hong Kong Polytechnic University |
2020-03-31 |
| NCT02036060 |
Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer. |
https://ClinicalTrials.gov/show/NCT02036060 |
Active, not recruiting |
Spanish Oncology Genito-Urinary Group |
2020-04-30 |
| NCT02481648 |
Feasibility of Measuring Exercise’s Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02481648 |
Active, not recruiting |
Vancouver Prostate Centre |
2018-12-31 |
| NCT02431702 |
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant’s With Recent-onset Schizophrenia or Schizophreniform |
https://ClinicalTrials.gov/show/NCT02431702 |
Completed |
Janssen Scientific Affairs, LLC |
2019-11-12 |
| NCT02386735 |
Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD |
https://ClinicalTrials.gov/show/NCT02386735 |
Recruiting |
Cantonal Hosptal, Baselland |
2020-09-30 |
| NCT02371564 |
High Flow Oxygen Therapy in Patients Suffering From Chronic Obstructive Pulmonary Disease Exacerbation: Effects and Mechanisms of Action |
https://ClinicalTrials.gov/show/NCT02371564 |
Recruiting |
University Hospital, Angers |
2019-12-31 |
| NCT02312557 |
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide |
https://ClinicalTrials.gov/show/NCT02312557 |
Active, not recruiting |
OHSU Knight Cancer Institute |
2021-01-01 |
| NCT02305927 |
Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health |
https://ClinicalTrials.gov/show/NCT02305927 |
Completed |
Harvard School of Public Health |
2019-09-18 |
| NCT02234440 |
Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance |
https://ClinicalTrials.gov/show/NCT02234440 |
Completed |
Institute of Liver and Biliary Sciences, India |
2015-12-31 |
| NCT02221427 |
The Labour Progression Study, a Cluster Randomised Trial on Labour Progression for First Time Mothers |
https://ClinicalTrials.gov/show/NCT02221427 |
Active, not recruiting |
Ostfold Hospital Trust |
2017-03-31 |
| NCT02206503 |
Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM) |
https://ClinicalTrials.gov/show/NCT02206503 |
Completed |
Fondazione Neoplasie Sangue Onlus |
2015-04-30 |
| NCT02186184 |
Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial |
https://ClinicalTrials.gov/show/NCT02186184 |
Completed |
Beijing Tongren Hospital |
2017-06-30 |
| NCT02176018 |
Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine |
https://ClinicalTrials.gov/show/NCT02176018 |
Completed |
Cady, Roger, M.D. |
2017-02-28 |
| NCT02130167 |
Low Concentration Atropine for Myopia Progression in School Children |
https://ClinicalTrials.gov/show/NCT02130167 |
Completed |
Chang Gung Memorial Hospital |
2017-07-31 |
| NCT02113800 |
Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study |
https://ClinicalTrials.gov/show/NCT02113800 |
Recruiting |
AIO-Studien-gGmbH |
2019-09-30 |
| NCT02064491 |
Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC |
https://ClinicalTrials.gov/show/NCT02064491 |
Completed |
Finnish Lung Cancer Group |
2016-12-31 |
| NCT01300546 |
Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine |
https://ClinicalTrials.gov/show/NCT01300546 |
Completed |
Cady, Roger, M.D. |
2012-04-30 |
| NCT01299948 |
Progression of HIV-Disease Under Low Dose Corticosteroids |
https://ClinicalTrials.gov/show/NCT01299948 |
Completed |
Medical Mission Institute, Germany |
2011-03-31 |
| NCT02016365 |
Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis |
https://ClinicalTrials.gov/show/NCT02016365 |
Completed |
Umeå University |
2014-12-31 |
| NCT03242915 |
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Targetable Genetic Alterations, Previously Treated With Appropriate Targeted Agents, With Progressive Disease |
https://ClinicalTrials.gov/show/NCT03242915 |
Recruiting |
University of Michigan Rogel Cancer Center |
2021-08-31 |
| NCT01978951 |
Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand |
https://ClinicalTrials.gov/show/NCT01978951 |
Completed |
Bhumirajanagarindra Kidney Institute, Thailand |
2013-07-31 |
| NCT01944033 |
β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation |
https://ClinicalTrials.gov/show/NCT01944033 |
Completed |
University of Monastir |
2016-07-31 |
| NCT01899586 |
Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly |
https://ClinicalTrials.gov/show/NCT01899586 |
Completed |
Duke University |
2011-11-30 |
| NCT01881620 |
PET Enhanced CT Scan Performance in Cancer |
https://ClinicalTrials.gov/show/NCT01881620 |
Completed |
Institut Bergonié |
2012-07-19 |
| NCT01840592 |
Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib |
https://ClinicalTrials.gov/show/NCT01840592 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-04-30 |
| NCT04400058 |
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression |
https://ClinicalTrials.gov/show/NCT04400058 |
Recruiting |
Octapharma |
2020-12-30 |
| NCT01737450 |
Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive |
https://ClinicalTrials.gov/show/NCT01737450 |
Completed |
Centre Leon Berard |
2018-09-30 |
| NCT01684761 |
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01684761 |
Completed |
Opexa Therapeutics, Inc. |
2016-10-31 |
| NCT01656278 |
An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01656278 |
Completed |
King Christian X´Hospital for Rheumatic Diseases |
2017-05-31 |
| NCT01591590 |
Correlating the Tumoral Metabolic Progression Index to Patient’s Outcome in Advanced Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT01591590 |
Active, not recruiting |
Jules Bordet Institute |
2019-06-30 |
| NCT01556100 |
Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson’s Disease Progression |
https://ClinicalTrials.gov/show/NCT01556100 |
Completed |
Chang Gung Memorial Hospital |
2015-05-31 |
| NCT01480986 |
IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC |
https://ClinicalTrials.gov/show/NCT01480986 |
Completed |
Peking University |
2012-09-30 |
| NCT01453257 |
Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients |
https://ClinicalTrials.gov/show/NCT01453257 |
Completed |
Grupo Hospital de Madrid |
2011-10-31 |
| NCT01437488 |
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy |
https://ClinicalTrials.gov/show/NCT01437488 |
Completed |
Thomas Jefferson University |
2014-08-04 |
| NCT01425957 |
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment |
https://ClinicalTrials.gov/show/NCT01425957 |
Completed |
Qualissima |
2015-08-31 |
| NCT01425112 |
Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy |
https://ClinicalTrials.gov/show/NCT01425112 |
Completed |
Sudhalkar Eye Hospital |
2011-05-31 |
| NCT01425073 |
Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya |
https://ClinicalTrials.gov/show/NCT01425073 |
Completed |
University of Washington |
2013-10-31 |
| NCT01350882 |
Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation |
https://ClinicalTrials.gov/show/NCT01350882 |
Completed |
University Hospital, Tours |
2012-10-31 |
| NCT01328951 |
A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy |
https://ClinicalTrials.gov/show/NCT01328951 |
Completed |
Hoffmann-La Roche |
2015-12-31 |
| NCT04436120 |
Treatment Resistance Following Anti-cancer Therapies |
https://ClinicalTrials.gov/show/NCT04436120 |
Recruiting |
Pfizer |
2020-12-30 |
| NCT04429867 |
Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease |
https://ClinicalTrials.gov/show/NCT04429867 |
Active, not recruiting |
WellStar Health System |
2020-12-07 |
| NCT04374526 |
Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. |
https://ClinicalTrials.gov/show/NCT04374526 |
Recruiting |
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
2020-09-30 |
| NCT04371510 |
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients |
https://ClinicalTrials.gov/show/NCT04371510 |
Recruiting |
Centre Hospitalier Universitaire de Nice |
2020-10-22 |
| NCT04369456 |
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients |
https://ClinicalTrials.gov/show/NCT04369456 |
Recruiting |
Centre Hospitalier Universitaire de Nice |
2020-10-22 |
| NCT04313023 |
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04313023 |
Recruiting |
Pulmotect, Inc. |
2020-09-30 |
| NCT04295707 |
Monthly Replacement Orthokeratology for Myopia Control in Existing Lens Wearers |
https://ClinicalTrials.gov/show/NCT04295707 |
Recruiting |
The Hong Kong Polytechnic University |
2022-09-30 |
| NCT04274933 |
A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy |
https://ClinicalTrials.gov/show/NCT04274933 |
Recruiting |
AbbVie |
2021-03-28 |
| NCT04245397 |
SX-682 Treatment in Subjects With Myelodysplastic Syndrome Who Had Disease Progression or Are Intolerant to Prior Therapy |
https://ClinicalTrials.gov/show/NCT04245397 |
Recruiting |
Syntrix Biosystems, Inc. |
2022-05-31 |
| NCT04223050 |
Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation |
https://ClinicalTrials.gov/show/NCT04223050 |
Recruiting |
Sydvestjysk Hospital |
2020-07-30 |
| NCT04205838 |
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT04205838 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2021-12-01 |
| NCT04150575 |
A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy |
https://ClinicalTrials.gov/show/NCT04150575 |
Recruiting |
Shanghai Henlius Biotech |
2021-06-15 |
| NCT04131634 |
Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT04131634 |
Recruiting |
University of Texas Southwestern Medical Center |
2021-12-16 |
| NCT04131491 |
Epilepsy in Alzheimer’s Disease: Effect on Disease Progression |
https://ClinicalTrials.gov/show/NCT04131491 |
Recruiting |
Universitair Ziekenhuis Brussel |
2023-09-30 |
| NCT04098406 |
Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT04098406 |
Recruiting |
Clene Nanomedicine |
2021-04-30 |
| NCT04072601 |
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT04072601 |
Recruiting |
Copenhagen University Hospital, Hvidovre |
2022-12-31 |
| NCT04033432 |
sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04033432 |
Recruiting |
Northwestern University |
2021-06-03 |
| NCT04017650 |
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT04017650 |
Recruiting |
M.D. Anderson Cancer Center |
2024-06-30 |
| NCT04007744 |
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT04007744 |
Recruiting |
Mayo Clinic |
2021-07-31 |
| NCT03992456 |
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT03992456 |
Recruiting |
Academic and Community Cancer Research United |
2021-08-07 |
| NCT03990571 |
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma |
https://ClinicalTrials.gov/show/NCT03990571 |
Recruiting |
M.D. Anderson Cancer Center |
2022-12-30 |
| NCT03973112 |
A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients With Disease Progression or Intolerant Toxicity After Standard Treatment |
https://ClinicalTrials.gov/show/NCT03973112 |
Recruiting |
Shanghai Henlius Biotech |
2021-12-15 |
| NCT03949101 |
Atropine for Children and Adolescent Myopia Progression Study |
https://ClinicalTrials.gov/show/NCT03949101 |
Enrolling by invitation |
Shanghai Eye Disease Prevention and Treatment Center |
2021-05-08 |
| NCT03943459 |
Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease |
https://ClinicalTrials.gov/show/NCT03943459 |
Recruiting |
InCor Heart Institute |
2022-04-30 |
| NCT03887741 |
Plasmapheresis Versus Plasma Infusion From Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression |
https://ClinicalTrials.gov/show/NCT03887741 |
Enrolling by invitation |
Mayo Clinic |
2021-12-31 |
| NCT03862807 |
Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant |
https://ClinicalTrials.gov/show/NCT03862807 |
Active, not recruiting |
Alnylam Pharmaceuticals |
2021-01-31 |
| NCT03703050 |
Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+ Anaplastic Large Cell Lymphoma, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) |
https://ClinicalTrials.gov/show/NCT03703050 |
Recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2024-01-31 |
| NCT03652298 |
Effects of a Neuroscience-based Technique on Post-traumatic Stress Disorder Symptoms, Inflammation, and Survival in Cancer Patients Announced of a Palliative Disease Progression and Their Partners |
https://ClinicalTrials.gov/show/NCT03652298 |
Recruiting |
Centre Oscar Lambret |
2020-05-25 |
| NCT03625466 |
A Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del |
https://ClinicalTrials.gov/show/NCT03625466 |
Active, not recruiting |
Vertex Pharmaceuticals Incorporated |
2020-11-30 |
| NCT03617757 |
Progression From Impaired Fasting Glucose to Diabetes Mellitus Among Chinese |
https://ClinicalTrials.gov/show/NCT03617757 |
Completed |
The University of Hong Kong |
2019-01-22 |
| NCT03601624 |
Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans |
https://ClinicalTrials.gov/show/NCT03601624 |
Recruiting |
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado |
2018-12-31 |
| NCT03594656 |
Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson’s Disease |
https://ClinicalTrials.gov/show/NCT03594656 |
Recruiting |
Xuanwu Hospital, Beijing |
2019-06-30 |
| NCT03586661 |
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
https://ClinicalTrials.gov/show/NCT03586661 |
Recruiting |
M.D. Anderson Cancer Center |
2021-04-30 |
| NCT03582488 |
Longitudinal Imaging Biomarkers of Disease Progression in DLB |
https://ClinicalTrials.gov/show/NCT03582488 |
Enrolling by invitation |
Mayo Clinic |
2023-06-25 |
| NCT03546426 |
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies |
https://ClinicalTrials.gov/show/NCT03546426 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2021-01-31 |
| NCT03514901 |
To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib. |
https://ClinicalTrials.gov/show/NCT03514901 |
Recruiting |
Intergruppo Melanoma Italiano |
2021-04-03 |
| NCT03513666 |
A Study of Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment |
https://ClinicalTrials.gov/show/NCT03513666 |
Active, not recruiting |
Shanghai Junshi Bioscience Co., Ltd. |
2019-10-22 |
| NCT03492450 |
Unraveling Early Walking Dysfunction in Non-disabled MS People: Assessment and Potential Therapeutic Interventions |
https://ClinicalTrials.gov/show/NCT03492450 |
Recruiting |
Fondazione Don Carlo Gnocchi Onlus |
2019-12-31 |
| NCT03469804 |
Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi’s Sarcoma |
https://ClinicalTrials.gov/show/NCT03469804 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-03-20 |
| NCT01238172 |
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance |
https://ClinicalTrials.gov/show/NCT01238172 |
Completed |
Alliance for Clinical Trials in Oncology |
2017-11-18 |
| NCT01230710 |
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression |
https://ClinicalTrials.gov/show/NCT01230710 |
Completed |
Hoffmann-La Roche |
2013-09-30 |
| NCT01174368 |
Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T |
https://ClinicalTrials.gov/show/NCT01174368 |
Completed |
The Rogosin Institute |
2016-12-31 |
| NCT01111461 |
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression |
https://ClinicalTrials.gov/show/NCT01111461 |
Completed |
Eisai Inc. |
2012-05-31 |
| NCT01077739 |
A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin |
https://ClinicalTrials.gov/show/NCT01077739 |
Completed |
Hoffmann-La Roche |
2012-01-31 |
| NCT01050322 |
Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment. |
https://ClinicalTrials.gov/show/NCT01050322 |
Completed |
Latin American Cooperative Oncology Group |
2010-12-31 |
| NCT00993499 |
Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib |
https://ClinicalTrials.gov/show/NCT00993499 |
Completed |
Boehringer Ingelheim |
2014-09-30 |
| NCT00944918 |
Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI) |
https://ClinicalTrials.gov/show/NCT00944918 |
Completed |
AstraZeneca |
2011-06-30 |
| NCT00943670 |
Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression |
https://ClinicalTrials.gov/show/NCT00943670 |
Completed |
Genentech, Inc. |
2010-12-31 |
| NCT00860431 |
Kremezin Study Against Renal Disease Progression in Korea |
https://ClinicalTrials.gov/show/NCT00860431 |
Completed |
Seoul National University Hospital |
2013-09-30 |
| NCT04343794 |
Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 |
https://ClinicalTrials.gov/show/NCT04343794 |
Recruiting |
The University of Hong Kong |
2021-12-31 |
| NCT04005144 |
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04005144 |
Recruiting |
University of California, San Francisco |
2022-08-01 |
| NCT03753334 |
Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer. |
https://ClinicalTrials.gov/show/NCT03753334 |
Active, not recruiting |
CHU de Quebec-Universite Laval |
2020-12-31 |
| NCT03976375 |
Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008) |
https://ClinicalTrials.gov/show/NCT03976375 |
Recruiting |
Merck Sharp & Dohme Corp. |
2023-08-21 |
| NCT02499068 |
Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home Telemonitoring |
https://ClinicalTrials.gov/show/NCT02499068 |
Completed |
Fundación Teófilo Hernando, Spain |
2016-06-01 |
| NCT00800800 |
Effects of Rosuvastatin on Aortic Stenosis Progression |
https://ClinicalTrials.gov/show/NCT00800800 |
Completed |
AstraZeneca |
2008-09-30 |
| NCT00707369 |
Adjunctive Antimicrobial Therapy of Periodontitis: Long-Term Effects on Disease Progression and Oral Microbiological Colonization |
https://ClinicalTrials.gov/show/NCT00707369 |
Completed |
University Hospital Muenster |
2011-12-31 |
| NCT00567983 |
Topical Cyclosporine and Disease Progression |
https://ClinicalTrials.gov/show/NCT00567983 |
Completed |
Innovative Medical |
2008-09-30 |
| NCT00800098 |
Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee |
https://ClinicalTrials.gov/show/NCT00800098 |
Completed |
Stanford University |
2009-09-30 |
| NCT00507221 |
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression |
https://ClinicalTrials.gov/show/NCT00507221 |
Completed |
University of Washington |
2011-07-31 |
| NCT00503685 |
Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy |
https://ClinicalTrials.gov/show/NCT00503685 |
Completed |
Eli Lilly and Company |
2009-03-31 |
| NCT00499876 |
The Effect of Malaria on Disease Progression of HIV/AIDS |
https://ClinicalTrials.gov/show/NCT00499876 |
Completed |
London School of Hygiene and Tropical Medicine |
2008-10-31 |
| NCT00456365 |
Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
https://ClinicalTrials.gov/show/NCT00456365 |
Completed |
University of Colorado, Denver |
2012-10-31 |
| NCT00415259 |
Effects of Shoes Insoles on Symptoms and Disease Progression in Knee Osteoarthritis |
https://ClinicalTrials.gov/show/NCT00415259 |
Completed |
University of Melbourne |
2008-12-31 |
| NCT00404170 |
Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease |
https://ClinicalTrials.gov/show/NCT00404170 |
Completed |
Institute for Neurodegenerative Disorders |
2014-07-31 |
| NCT00383669 |
A Trial of Vitamins and HAART in HIV Disease Progression |
https://ClinicalTrials.gov/show/NCT00383669 |
Completed |
Harvard School of Public Health |
2009-10-31 |
| NCT00335049 |
Study of Theories About Myopia Progression (STAMP) |
https://ClinicalTrials.gov/show/NCT00335049 |
Completed |
Ohio State University |
2010-07-31 |
| NCT00221845 |
Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT00221845 |
Completed |
Heidelberg University |
2007-07-31 |
| NCT00214487 |
Bifocal Soft Contact Lenses and Their Effect on Myopia Progression in Children and Adolescents. |
https://ClinicalTrials.gov/show/NCT00214487 |
Completed |
Aller, Thomas A., OD |
2006-03-31 |
| NCT00063726 |
A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 |
https://ClinicalTrials.gov/show/NCT00063726 |
Completed |
Millennium Pharmaceuticals, Inc. |
2005-05-31 |
| NCT00006144 |
A Study of HIV-Disease Development in Aging |
https://ClinicalTrials.gov/show/NCT00006144 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00001068 |
A Study of Disease Progression and Anti-HIV Treatments |
https://ClinicalTrials.gov/show/NCT00001068 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000653 |
A Trial of Two Doses of 2’,3’-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT |
https://ClinicalTrials.gov/show/NCT00000653 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |